Patents by Inventor Lynne V. Nazareth

Lynne V. Nazareth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified polypeptide fragments of the glucocorticoid receptor
    Patent number: 5571791
    Abstract: A cell lysis factor which is a modified fragment of the human glucocorticoid receptor. The modified fragment designated 398-465*, when transfected into and expressed in a host cell, effects cell lysis and cell death. A pharmaceutical composition having the modified fragment 398-465* or the encoded protein product may be used in treatment of proliferative diseases.
    Type: Grant
    Filed: November 20, 1995
    Date of Patent: November 5, 1996
    Assignee: Board of Regents, The University of Texas System
    Inventors: E. Brad Thompson, Lynne V. Nazareth
  • Cell lysis activity of a modified fragment of the glucocorticoid receptor
    Patent number: 5468624
    Abstract: A cell lysis factor which is a modified fragment of the human glucocorticoid receptor. The modified fragment designated 398-465*, when transfected into and expressed in a host cell, effects cell lysis and cell death. A pharmaceutical composition having the modified fragment 398-465* or the encoded protein product may be used in treatment of proliferative diseases.
    Type: Grant
    Filed: July 2, 1993
    Date of Patent: November 21, 1995
    Assignee: Board of Regents, the University of Texas System
    Inventors: E. Brad Thompson, Lynne V. Nazareth